The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination Trial
Introduction. The prognosis of acute coronary syndrome (ACS) patients has been improved with several treatments such as antithrombotics, beta-blockers, and angiotensin-converting enzyme inhibitors (ACEI) as well as coronary revascularization. Influenza vaccination has been shown to reduce adverse ou...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Cardiology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2016/4097471 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832549253675745280 |
|---|---|
| author | Apirak Sribhutorn Arintaya Phrommintikul Wanwarang Wongcharoen Usa Chaikledkaew Suntara Eakanunkul Apichard Sukonthasarn |
| author_facet | Apirak Sribhutorn Arintaya Phrommintikul Wanwarang Wongcharoen Usa Chaikledkaew Suntara Eakanunkul Apichard Sukonthasarn |
| author_sort | Apirak Sribhutorn |
| collection | DOAJ |
| description | Introduction. The prognosis of acute coronary syndrome (ACS) patients has been improved with several treatments such as antithrombotics, beta-blockers, and angiotensin-converting enzyme inhibitors (ACEI) as well as coronary revascularization. Influenza vaccination has been shown to reduce adverse outcomes in ACS, but no information exists regarding the interaction of other treatments. Methods. This study included 439 ACS patients from Phrommintikul et al. A single dose of inactivated influenza vaccine was given by intramuscular injection in the vaccination group. The cardiovascular outcomes were described as major cardiovascular events (MACEs) which included mortality, hospitalization due to ACS, and hospitalization due to heart failure (HF). The stratified and multivariable Cox’s regression analysis was performed. Results. The stratified Cox’s analysis by influenza vaccination for each cardiovascular outcome and discrimination of hazard ratios showed that beta-blockers had an interaction with influenza vaccination. Moreover, the multivariable hazard ratios disclosed that influenza vaccine is associated with a significant reduction of hospitalization due to HF in patients who received beta-blockers (HR = 0.05, 95% CI = 0.004–0.71, P=0.027), after being adjusted for prognostic indicators (sex, dyslipidemia, serum creatinine, and left ventricular ejection fraction). Conclusions. The influenza vaccine was shown to significantly modify the effect of beta-blockers in ACS patients and to reduce the hospitalization due to HF. However, further study of a larger population and benefits to HF patients should be investigated. |
| format | Article |
| id | doaj-art-afb49c6713004a47b36fdf77d2215e18 |
| institution | Kabale University |
| issn | 2090-8016 2090-0597 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cardiology Research and Practice |
| spelling | doaj-art-afb49c6713004a47b36fdf77d2215e182025-02-03T06:11:46ZengWileyCardiology Research and Practice2090-80162090-05972016-01-01201610.1155/2016/40974714097471The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination TrialApirak Sribhutorn0Arintaya Phrommintikul1Wanwarang Wongcharoen2Usa Chaikledkaew3Suntara Eakanunkul4Apichard Sukonthasarn5Ph.D. Program in Clinical Epidemiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, ThailandCardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, ThailandCardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, ThailandSocial and Administrative Pharmacy Excellence Research (SAPER) Unit, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok 10400, ThailandDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, ThailandCardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, ThailandIntroduction. The prognosis of acute coronary syndrome (ACS) patients has been improved with several treatments such as antithrombotics, beta-blockers, and angiotensin-converting enzyme inhibitors (ACEI) as well as coronary revascularization. Influenza vaccination has been shown to reduce adverse outcomes in ACS, but no information exists regarding the interaction of other treatments. Methods. This study included 439 ACS patients from Phrommintikul et al. A single dose of inactivated influenza vaccine was given by intramuscular injection in the vaccination group. The cardiovascular outcomes were described as major cardiovascular events (MACEs) which included mortality, hospitalization due to ACS, and hospitalization due to heart failure (HF). The stratified and multivariable Cox’s regression analysis was performed. Results. The stratified Cox’s analysis by influenza vaccination for each cardiovascular outcome and discrimination of hazard ratios showed that beta-blockers had an interaction with influenza vaccination. Moreover, the multivariable hazard ratios disclosed that influenza vaccine is associated with a significant reduction of hospitalization due to HF in patients who received beta-blockers (HR = 0.05, 95% CI = 0.004–0.71, P=0.027), after being adjusted for prognostic indicators (sex, dyslipidemia, serum creatinine, and left ventricular ejection fraction). Conclusions. The influenza vaccine was shown to significantly modify the effect of beta-blockers in ACS patients and to reduce the hospitalization due to HF. However, further study of a larger population and benefits to HF patients should be investigated.http://dx.doi.org/10.1155/2016/4097471 |
| spellingShingle | Apirak Sribhutorn Arintaya Phrommintikul Wanwarang Wongcharoen Usa Chaikledkaew Suntara Eakanunkul Apichard Sukonthasarn The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination Trial Cardiology Research and Practice |
| title | The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination Trial |
| title_full | The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination Trial |
| title_fullStr | The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination Trial |
| title_full_unstemmed | The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination Trial |
| title_short | The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination Trial |
| title_sort | modification effect of influenza vaccine on prognostic indicators for cardiovascular events after acute coronary syndrome observations from an influenza vaccination trial |
| url | http://dx.doi.org/10.1155/2016/4097471 |
| work_keys_str_mv | AT apiraksribhutorn themodificationeffectofinfluenzavaccineonprognosticindicatorsforcardiovasculareventsafteracutecoronarysyndromeobservationsfromaninfluenzavaccinationtrial AT arintayaphrommintikul themodificationeffectofinfluenzavaccineonprognosticindicatorsforcardiovasculareventsafteracutecoronarysyndromeobservationsfromaninfluenzavaccinationtrial AT wanwarangwongcharoen themodificationeffectofinfluenzavaccineonprognosticindicatorsforcardiovasculareventsafteracutecoronarysyndromeobservationsfromaninfluenzavaccinationtrial AT usachaikledkaew themodificationeffectofinfluenzavaccineonprognosticindicatorsforcardiovasculareventsafteracutecoronarysyndromeobservationsfromaninfluenzavaccinationtrial AT suntaraeakanunkul themodificationeffectofinfluenzavaccineonprognosticindicatorsforcardiovasculareventsafteracutecoronarysyndromeobservationsfromaninfluenzavaccinationtrial AT apichardsukonthasarn themodificationeffectofinfluenzavaccineonprognosticindicatorsforcardiovasculareventsafteracutecoronarysyndromeobservationsfromaninfluenzavaccinationtrial AT apiraksribhutorn modificationeffectofinfluenzavaccineonprognosticindicatorsforcardiovasculareventsafteracutecoronarysyndromeobservationsfromaninfluenzavaccinationtrial AT arintayaphrommintikul modificationeffectofinfluenzavaccineonprognosticindicatorsforcardiovasculareventsafteracutecoronarysyndromeobservationsfromaninfluenzavaccinationtrial AT wanwarangwongcharoen modificationeffectofinfluenzavaccineonprognosticindicatorsforcardiovasculareventsafteracutecoronarysyndromeobservationsfromaninfluenzavaccinationtrial AT usachaikledkaew modificationeffectofinfluenzavaccineonprognosticindicatorsforcardiovasculareventsafteracutecoronarysyndromeobservationsfromaninfluenzavaccinationtrial AT suntaraeakanunkul modificationeffectofinfluenzavaccineonprognosticindicatorsforcardiovasculareventsafteracutecoronarysyndromeobservationsfromaninfluenzavaccinationtrial AT apichardsukonthasarn modificationeffectofinfluenzavaccineonprognosticindicatorsforcardiovasculareventsafteracutecoronarysyndromeobservationsfromaninfluenzavaccinationtrial |